Storys aus Switzerland,

Helsinn Healthcare SA

Swiss-based Helsinn Group and Mundipharma sign for rights to Phase III Netupitant-Palonosetron fixed dose combination for China

Lugano, Switzerland (ots) - The two companies sign a distribution and license agreement for an investigational therapy for the prevention of chemotherapy-induced nausea and vomiting covering China, Hong Kong and Macao Helsinn and Mundipharma announce the signature of a new, exclusive license and distribution ...

Helsinn Healthcare SA

Swiss-based Helsinn Group and Mundipharma sign for rights to Phase III Netupitant-Palonosetron fixed dose combination for China

Lugano, Switzerland (ots) - The two companies sign a distribution and license agreement for an investigational therapy for the prevention of chemotherapy-induced nausea and vomiting covering China, Hong Kong and Macao Helsinn and Mundipharma announce the signature of a new, exclusive license and distribution ...

Helsinn Healthcare SA

Helsinn and Italfarmaco reinforce their alliance through the grant of rights to phase-III ghrelin receptor agonist Anamorelin in Italy

Lugano, Switzerland (ots) - Helsinn Group grants exclusive distribution and licensing rights to Italfarmaco for the commercialization of its compound currently in development for the treatment of anorexia-cachexia syndrome related to non-small cell lung cancer (NSCLC) Helsinn Group is pleased to announce that ...

Takeda Pharmaceuticals Europe Ltd

Takeda Launches New Subsidiary in Israel

Zurich, Switzerland (ots/PRNewswire) - Demonstrates Takeda's commitment to bring new, innovative treatments to patients Takeda Pharmaceuticals International GmbH ("Takeda") today announced further expansion of its commercial platform with the establishment of its wholly-owned subsidiary in Israel. Together with Algeria, Ecuador, Peru, Singapore and Vietnam, Israel is the sixth sales entity Takeda has opened this year to ...

Biosafe Group

BIOSAFE targets Latin American expansion

Eysins, Switzerland (ots) - Following the set-up of a Shanghai-based Chinese subsidiary and its recent expansion in India, Biosafe is demonstrating its firm commitment to emerging markets with the creation of a new subsidiary and the opening today of a new office covering the Latin American area. The new company, Biosafe do Brasil Participaçôes e Representações Ltda., based in the Vila Olímpia quarter of São Paulo ...

WISeKey SA

DOHA GOALS 2013: WISeKey Presents the 'Fully Connected' Future of Sports: Fan Apps and Stadium Hub Technology Combine for 24/7 Global Engagement (PICTURE)

Helsinn Healthcare SA

Helsinn Group and Eisai announce FDA acceptance of New Drug Application for investigational compound netupitant 300 mg + palonosetron 0.50 mg (NEPA)

Lugano, Switzerland/Woodcliff Lake, NJ, USA (ots) - Seeking indication for prevention of chemotherapy-induced nausea and vomiting Helsinn Group and Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) accepted for review the submission of the New Drug Application (NDA) for the investigational ...

Biocartis

Biocartis and VIB Join Forces to Develop Unique Diagnostic Cancer Test

Lausanne, Switzerland And Mechelen, Belgium (ots/PRNewswire) - Today Biocartis and VIB announced their exclusive license agreement on a novel panel of microsatellite instability (MSI) biomarkers for several cancers, in particular colorectal cancer (CRC). This agreement will enable Biocartis to develop a unique and user-friendly assay, whereby MSI biomarkers can simply ...

Helsinn Healthcare SA

Helsinn Group's representative office in China: Official inauguration

Lugano, Switzerland - Beijing, PRC (ots) - Helsinn Group, the independent, privately-owned, Swiss pharmaceutical company, with a worldwide presence built over 35 years, lands in China. Helsinn's Representative Office was officially inaugurated in Beijing, PRC yesterday. With headquarters in Lugano, Switzerland, and operating subsidiaries in Ireland and the United ...

Debiopharm International SA

BPA Solutions get Investment funds to accelerate rapid growth and global expansion

Yverdon, Switzerland (ots) - BPA Solutions SA (BPA), headquartered at Swiss Technopole Yverdon, Switzerland, today announced it has raised development funds from Debiopharm Investment. BPA is a global leading provider of innovative business software solutions based on Microsoft (MS) SharePoint technologies with 800+ customers and 50+ partners worldwide. Profitable ...

European Broadcasting Union (EBU)

EBU partners with the european film academy to launch EUROVISION FILM WEEK, 1-7 dec 2013

Geneva, Switzerland (ots) - The European Broadcasting Union (EBU) and 26 of its Members, with cooperation from the European Film Academy (EFA) (http://www.europeanfilmacademy.org/European-Film-Awards.36.0.html) have joined forces to launch EUROVISION FILM WEEK - the most accessible film festival (http://ots.de/DMmQo) anywhere, and the first ever based exclusively on TV ...

Auriga Credit Network

Collect accounts receivable with a click of the mouse - Auriga Credit Network introduces a new solution for international debt collection

Pfäffikon, Switzerland (ots) - Every entrepreneur is familiar with the following scenario: the services or goods have been delivered - but the business partner abroad fails to settle the account. Whereas in Germany a suitable reaction would be to send a brief, business-like reminder, in Austria business partners ...

REHA Technology AG

Reha Technology AG sells first G-EO System unit in India and opens Indian subsidiary

Olten, Switzerland (ots) - Reha Technology AG will be installing the first G-EO System unit in India with Dr. Zameer Jafri at the Max Balaji Super Specialty Healthcare in New Delhi and is launching direct operations in India. Launch of Indian direct operations in New Delhi Reha Technology AG, a Swiss company that designs, manufactures and globally distributes advanced ...

Helsinn Healthcare SA

Helsinn and Chugai Pharma Marketing enter into agreement for rights of Anamorelin,currently in development for treatment of anorexia-cachexia syndrome related to non-small cell lung cancer in top EU markets

Lugano, Switzerland (ots) - Swiss Pharma Group Helsinn seals an alliance with Japanese company Chugai by granting exclusive distribution & licensing rights to commercialize its innovative phase III ghrelin receptor agonist in Germany, France, Benelux, UK and Ireland Swiss-based Helsinn group has granted Chugai ...

Biocartis

Biocartis Poised for 2014 Commerical Launch with EUR 30 Million Series E Equity Fundraising

Mechelen, Belgium And Lausanne, Switzerland (ots/PRNewswire) - Biocartis, a molecular diagnostics company developing and commercializing innovative, easy to use platforms and clinically relevant assays, announced today the completion of an EUR 30 million Series E equity fundraising. The additional capital will be ...

Biosafe Group

BIOSAFE's latest innovation: Smart-Max

Eysins, Switzerland (ots) - Biosafe is pleased to report the launch of its new Smart-Max device at the ESH World Cord Blood Congress in Monaco last week. The Smart-Max device has multiple areas of application in cell processing, including cell mixing, cooling, thawing, dilution, incubation and digestion. It is fully automated with an easy-to-use touchscreen interface and can handle bags of various sizes. Used in ...

Biocartis

Biocartis Presents the Successful use of Idylla[TM] for the Detection of the BRAF Mutation Status in Tumour Samples at the International AACR Congress (American Association for Cancer Research) in Boston

Mechelen, Belgium And Lausanne, Switzerland (ots/PRNewswire) - Biocartis also introduces IdyllaTM, the brand name for its innovative and high-quality diagnostic platform (previously codenamed Apollo). IdyllaTM is designed to carry out fast and accurate analysis of a broad range of clinical samples[1]. The platform ...

Biocartis

Biocartis and Hospital del Mar (Barcelona, Spain) Join Forces to Develop Diagnostic Colon Cancer Test

Lausanne, Switzerland, Mechelen, Belgium And Barcelona, Spain (ots/PRNewswire) - Today Biocartis and Hospital del Mar announced their licence agreement on the EGFR biomarker for colon cancer. This agreement enables Biocartis to develop a new colon cancer test, whereby a specific EGFR mutation can be rapidly and ...

The International Osteoporosis Foundation (IOF)

Woman at serious risk for osteoporosis and life-threatening fractures

Nyon, Switzerland (ots) - On World Osteoporosis Day, October 20, the International Osteoporosis Foundation (IOF) is calling for women to take action now to protect their bone health. Broken bones due to osteoporosis often result in pain, immobility and loss of quality of life as well as early death. In women over 45 years of age, osteoporosis accounts for more days ...

Helsinn Healthcare SA

Helsinn to launch sales organization in the United States

Lugano, Switzerland (ots) - The Swiss Helsinn Group announced today the formation of a sales organization in the US subsidiary, Helsinn Therapeutics (US) Inc. A commercial organization of 20 people has been engaged throughout the United States. The new oncology sales representatives will be working via a co-detailing agreement for Aloxi® (palonosetron HCl injection), licensed by the Helsinn Group to Eisai, Inc. The ...

Biosafe Group

BIOSAFE affirms its leadership in India

Eysins, Switzerland (ots) - Biosafe is pleased to announce that, in partnership with its Indian Distributor Span Healthcare Private Ltd., it has achieved major expansion of its stem cell banking business in India, winning major new customer deals consecutively. In the public stem cell banking area, Jeevan Blood Bank and Research Centre in Chennai is expanding its program and will process its full volume of stem cell ...

MESA Medical Equipment Solutions and Applications

MESA makes strategic investment in MVS Poland to advance Pan-European multi-vendor offering for diagnostic imaging service, equipment and parts

Lugano, Switzerland and Mikolow, Poland (ots) - Culminating from a three-year relationship involving operational synergies for diagnostic imaging service and equipment solutions, two of the largest multi-vendor service providers in Europe: Pan-European, Swiss-based Medical Equipment Solutions and Applications (MESA) ...

Biocartis

Biocartis Strengthens Management Team With Chief Commercial Officer

Lausanne, Switzerland And Mechelen, Belgium (ots/PRNewswire) - Biocartis, a molecular diagnostics company, announces today that Ulrik Cordes has joined the company as Chief Commercial Officer (CCO). Ulrik Cordes is an executive with 18+ years of experience in marketing and sales in the med-tech, pharma and biotech industry, of which the past 10 years in top level management roles. "We are delightedtowelcomeUlrik to ...

Infront Sports & Media AG

Infront fosters further organic growth with the opening of a new Pan-Asia subsidiary in Singapore

Singapore/Zug,Switzerland (ots) - The group takes its comprehensive sales, marketing and client services to the region, whilst also offering a gateway to its broad sports portfolio Infront Sports & Media, the leading international sports marketing company, has opened a new office in Singapore. The wholly-owned subsidiary under the name Infront Pan-Asia became fully ...